kenvue.com - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi KVUE
On the GURU.Markets platform, Kenvue Inc. (KVUE) absolute EBITDA reflects profit dynamics, where the 3594.19 mark indicates the current state. Stable cash flow is driven by loyalty to essential brands. High barriers to entry are created by well-known brands and FDA oversight. Production efficiency is maintained by robotic assembly lines, which completely eliminate manual labor during product packaging.
Ringkesan rincian data analitis Kenvue (KVUE)
- nilai pasar lan prakiraan target analis:
- rincian nilai pasar emiten:
- statistik nilai buku emiten:
- rincian struktur utang lan likuiditas bisnis:
Rasio Kabeh Utang marang Dana Pribadi Kenvue Inc.|KVUE - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Kenvue Inc|KVUE - Gunggung utang perusahaan|Utang-utang marang nilai buku Kenvue|KVUE - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan Kenvue|Likuiditas cepet kenvue.com
- statistik bathi lan rasio pasar:
KVUE - Penghasilan resik|Proyeksi bathi mangsa ngarep Kenvue Inc.|KVUE - Pangali P/E|Rasio prakiraan rega marang bathi kenvue.com|KVUE - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Kenvue|KVUE - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Kenvue|KVUE - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan kenvue.com|KVUE - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Kenvue Inc.
Ringkesan analitik perusahaan:Kenvue Inc.
Fundamental asset screening begins with an assessment of a business's ability to generate cash flow. By analyzing absolute operating profit, an investor identifies the net cash balance from sales, stripped of the impact of taxes, interest, and depreciation. The trend of this absolute operating profit reveals the actual efficiency of cost management. For Kenvue Inc. (KVUE), this metric is critical due to pressure from retailers' private labels. Steady growth in this metric confirms the company's ability to withstand aggressive marketing in an oversaturated sector.
Pesaing Kenvue Inc. (KVUE)
Haleon Corp (HLN) - Bathi sadurunge bunga, pajak, lan amortisasi|VRNA: Bathi operasional sadurunge ngurangi amortisasi|jyongbio.com - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|LGND: Bathi operasional EBITDA|Amneal Pharmaceuticals, Inc. - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|PRGO (Perrigo Company) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Alvotech Biopharmaceuticals ALVO|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Liquidia Corporation (LQDA)|GLPG (glpg.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi ANI Pharmaceuticals, Inc. ANIP|Bathi operasional EBITDA MannKind Corp MNKD|Amphastar - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Pacira Corp|ARS Pharmaceuticals (SPRY) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge amortisasi TBPH|Bathi operasional sadurunge ngurangi amortisasi AQST|Bathi sadurunge mbayar bunga, pajak, lan amortisasi SCPH|Bathi operasional sadurunge ngurangi amortisasi TECX (Tectonic Therapeutic, Inc.)|Bathi operasional EBITDA Tonix Pharmaceuticals Holding (TNXP)|Bathi operasional EBITDA SXTC (China SXT Pharmaceuticals, Inc.)|Eupraxia Pharmaceuticals, Inc. (EPRX) - Bathi sadurunge bunga, pajak, lan amortisasi|BHST: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi EXOZ (Invizyne Technologies)|ORMP: Bathi operasional EBITDA|ENTX - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi MindWalk Holdings|Bathi operasional sadurunge amortisasi ABVC (abvcpharma.com)|Bathi operasional EBITDA CPIX|Bathi operasional sadurunge ngurangi amortisasi Quantum BioPharma Ltd. QNTM|FibroGen Corp - Bathi operasional sadurunge ngurangi amortisasi|Pendapatan operasional sadurunge ngurangi amortisasi Telomir Pharmaceuticals Corp (TELO)|RANI - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|SNYR - Bathi operasional EBITDA|RLYB (rallybio.com) - Bathi operasional sadurunge ngurangi amortisasi|LEXX (Lexaria Bioscience Corp.) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge ngurangi amortisasi PULM|Bathi operasional EBITDA Pheton|Bathi operasional EBITDA APM|LYRA - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Impact BioMedical IBO|TNFA (TNF Pharmaceuticals Inc.) - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|cbdMD Corp - Bathi operasional EBITDA|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi PRFX (PainReform Corp)|CYTO: Bathi operasional EBITDA|lipella.com (LIPO) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi OptiNose|PIRS: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Procaps Group SA (PROC)|Bathi operasional sadurunge ngurangi amortisasi Petros Pharma PTPI|Bathi operasional EBITDA QLI (Qilian International)|Bathi operasional EBITDA acelyrin.com SLRN|TFFP: Bathi operasional sadurunge ngurangi amortisasi
